Jill Leversage - Net Worth and Insider Trading
Jill Leversage Net Worth
The estimated net worth of Jill Leversage is at least $106,057 dollars as of 2025-05-04. Jill Leversage is the Director of Aurinia Pharmaceuticals Inc and owns about 12,918 shares of Aurinia Pharmaceuticals Inc (AUPH) stock worth over $106,057. Details can be seen in Jill Leversage's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jill Leversage has not made any transactions after 2024-05-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jill Leversage
Jill Leversage Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jill Leversage owns 1 companies in total, including Aurinia Pharmaceuticals Inc (AUPH) .
Click here to see the complete history of Jill Leversage’s form 4 insider trades.
Insider Ownership Summary of Jill Leversage
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc | 2024-05-21 | director |
Jill Leversage Latest Holdings Summary
Jill Leversage currently owns a total of 1 stock. Jill Leversage owns 12,918 shares of Aurinia Pharmaceuticals Inc (AUPH) as of May 21, 2024, with a value of $106,057.
Latest Holdings of Jill Leversage
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc | 2024-05-21 | 12,918 | 8.21 | 106,057 |
Holding Weightings of Jill Leversage
Jill Leversage Form 4 Trading Tracker
According to the SEC Form 4 filings, Jill Leversage has made a total of 5 transactions in Aurinia Pharmaceuticals Inc (AUPH) over the past 5 years, including 3 buys and 2 sells. The most-recent trade in Aurinia Pharmaceuticals Inc is the sale of 5,610 shares on May 21, 2024, which brought Jill Leversage around $32,201.
Insider Trading History of Jill Leversage
- 1
Jill Leversage Trading Performance
GuruFocus tracks the stock performance after each of Jill Leversage's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jill Leversage is -13.38%. GuruFocus also compares Jill Leversage's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jill Leversage within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jill Leversage's insider trading performs compared to the benchmark.
Performance of Jill Leversage
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.54 | | | | | |
| Relative Return to S&P 500(%) | -3.92 | | | | | |
Jill Leversage Ownership Network
Ownership Network List of Jill Leversage
Ownership Network Relation of Jill Leversage
Jill Leversage Owned Company Details
What does Aurinia Pharmaceuticals Inc do?
Who are the key executives at Aurinia Pharmaceuticals Inc?
Jill Leversage is the director of Aurinia Pharmaceuticals Inc. Other key executives at Aurinia Pharmaceuticals Inc include director & Chief Executive Officer Peter Greenleaf , Chief Financial Officer Joseph M Miller , and Ex VP & Intern'l Operations Matthew Maxwell Donley .
Aurinia Pharmaceuticals Inc (AUPH) Insider Trades Summary
Over the past 18 months, Jill Leversage made 1 insider transaction in Aurinia Pharmaceuticals Inc (AUPH) with a net sale of 5,610. Other recent insider transactions involving Aurinia Pharmaceuticals Inc (AUPH) include a net sale of 51,893 shares made by Scott Michael Habig , a net purchase of 2,800,000 shares made by Kevin C Tang , and a net sale of 487,521 shares made by Peter Greenleaf .
In summary, during the past 3 months, insiders sold 746,469 shares of Aurinia Pharmaceuticals Inc (AUPH) in total and bought 1,600,000 shares, with a net purchase of 853,531 shares. During the past 18 months, 1,120,396 shares of Aurinia Pharmaceuticals Inc (AUPH) were sold and 2,800,000 shares were bought by its insiders, resulting in a net purchase of 1,679,604 shares.
Aurinia Pharmaceuticals Inc (AUPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aurinia Pharmaceuticals Inc Insider Transactions
Jill Leversage Mailing Address
Above is the net worth, insider trading, and ownership report for Jill Leversage. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jill Leversage's mailing address is: Victoria A1 V8z 7x8.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
